Latest Urinary Tract Infections (UTI) News
Fluoroquinolones such as Cipro, Levaquin should be reserved for life-threatening infections.
Researchers find new training method led to fewer urinary tract infections.
Agency is recommending that health care providers not prescribe them for certain patients.
In a study, use of the medication was associated with a significant 61% decreased risk.
Could lead to greater reliance on much more costly intravenous medications.
Case presented of patient with extended-spectrum beta-lactamase E. coli infection.
Older age and a second episode of urinary tract infection identified as risk factors.
A safety review conducted by the Food and Drug Administration (FDA) has led to new warnings added to the prescribing information for sodium-glucose co-transporter 2 (SGLT2) inhibitors used to treat type 2 diabetes.
Antibiotics frequently initiated inappropriately in ER; continuation after admission inappropriate for 68
The cephalosporin antibiotic proved more effective than trimethoprim-sulfamethoxazole and amoxicillin.
New meta-analysis also found no significant difference in risk between antimicrobial agents in head-to-head trials.
The researchers found that factors associated with a higher risk of recurrent infections included type 2 diabetes mellitus, hypertension, and black ethnicity.
Findings for women undergoing elective gynecologic surgery involving urinary catheterization.
Female kidney recipients have a nearly 7-fold higher risk of UTI than their male counterparts.
Identifying illness correctly is key to drugs' effectiveness, researcher says.
- Race Affects Switch from Prostate Cancer Observation to Active Therapy
- Study: eGFR Trajectory More Predictive of Death in Type 2 Diabetes
- Flu Vaccine May Reduce Hospitalizations, Deaths in Type 2 Diabetes
- FDA Adds Safety Warnings to Fluoroquinolones
- PCa Active Surveillance Patients Enjoy Good Quality of Life
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)